Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A68930: a potent agonist specific for the dopamine D1 receptor.
Kebabian JW, DeNinno MP, Schoenleber R, MacKenzie R, Britton DR, Asin KE. Kebabian JW, et al. Among authors: schoenleber r. Neurochem Int. 1992 Mar;20 Suppl:157S-160S. doi: 10.1016/0197-0186(92)90230-o. Neurochem Int. 1992. PMID: 1365416
A68930: a potent agonist selective for the dopamine D1 receptor.
DeNinno MP, Schoenleber R, MacKenzie R, Britton DR, Asin KE, Briggs C, Trugman JM, Ackerman M, Artman L, Bednarz L, et al. DeNinno MP, et al. Among authors: schoenleber r. Eur J Pharmacol. 1991 Jun 25;199(2):209-19. doi: 10.1016/0014-2999(91)90459-4. Eur J Pharmacol. 1991. PMID: 1683288
A68930: a potent and specific agonist for the D-1 dopamine receptor.
Kebabian JW, Briggs C, Britton DR, Asin K, DeNinno M, MacKenzie RG, McKelvy JF, Schoenleber R. Kebabian JW, et al. Among authors: schoenleber r. Am J Hypertens. 1990 Jun;3(6 Pt 2):40S-42S. doi: 10.1093/ajh/3.6.40s. Am J Hypertens. 1990. PMID: 2143387 Review.
Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacy.
Rudolph J, Chen L, Majumdar D, Bullock WH, Burns M, Claus T, Dela Cruz FE, Daly M, Ehrgott FJ, Johnson JS, Livingston JN, Schoenleber RW, Shapiro J, Yang L, Tsutsumi M, Ma X. Rudolph J, et al. Among authors: schoenleber rw. J Med Chem. 2007 Mar 8;50(5):984-1000. doi: 10.1021/jm061299k. Epub 2007 Feb 3. J Med Chem. 2007. PMID: 17274610
Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity.
Rudolph J, Esler WP, O'connor S, Coish PD, Wickens PL, Brands M, Bierer DE, Bloomquist BT, Bondar G, Chen L, Chuang CY, Claus TH, Fathi Z, Fu W, Khire UR, Kristie JA, Liu XG, Lowe DB, McClure AC, Michels M, Ortiz AA, Ramsden PD, Schoenleber RW, Shelekhin TE, Vakalopoulos A, Tang W, Wang L, Yi L, Gardell SJ, Livingston JN, Sweet LJ, Bullock WH. Rudolph J, et al. Among authors: schoenleber rw. J Med Chem. 2007 Oct 18;50(21):5202-16. doi: 10.1021/jm070071+. Epub 2007 Sep 21. J Med Chem. 2007. PMID: 17887659
24 results